Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
451
-
Total 13F shares, excl. options
-
45.7M
-
Shares change
-
+376K
-
Total reported value, excl. options
-
$8.87B
-
Value change
-
+$75.6M
-
Put/Call ratio
-
1.52
-
Number of buys
-
239
-
Number of sells
-
-205
-
Price
-
$194.41
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2021
522 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q1 2021.
REPLIGEN CORP - COMMON STOCK (RGEN) has 451 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.7M shares
of 56.2M outstanding shares and own 81.2% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.86M shares), BlackRock Inc. (4.77M shares), Invesco Ltd. (2.29M shares), FRED ALGER MANAGEMENT, LLC (1.48M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.32M shares), Select Equity Group, L.P. (1.25M shares), STATE STREET CORP (1.19M shares), ALLIANCEBERNSTEIN L.P. (1.12M shares), 12 West Capital Management LP (1.09M shares), and Bank of New York Mellon Corp (1.08M shares).
This table shows the top 451 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.